TRML

COM:TOURMALINEBIO

Tourmaline Bio, Inc.

  • Stock

Last Close

23.50

20/11 21:00

Market Cap

352.13M

Beta: -

Volume Today

154.31K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
623K
-
6K
99.04%
33K
450%
gross profit
-623K
-
-6K
99.04%
-33K
450%
selling and marketing expenses
general and administrative expenses
692
-
2.17M
314,206.36%
13.04M
499.59%
selling general and administrative expenses
692
-
2.17M
314,206.36%
13.04M
499.59%
research and development expenses
212
-
17.53M
8,266,881.13%
32.37M
84.69%
other expenses
3.29M
-
cost and expenses
904
-
19.70M
2,179,214.16%
45.41M
130.49%
operating expenses
904
-
19.70M
2,179,214.16%
45.41M
130.49%
interest expense
ebitda
-46.88M
-
-19.70M
57.99%
-45.38M
130.39%
operating income
-904
-
-19.70M
2,179,214.16%
-45.41M
130.49%
depreciation and amortization
904
-
6K
563.72%
33K
450%
total other income expenses net
-326K
-
3.29M
-
income before tax
-904
-
-19.70M
2,179,214.16%
-42.12M
113.82%
income tax expense
-47.21M
-
net income
-904
-
-19.70M
2,179,214.16%
-42.12M
113.82%
weighted average shs out
10.88M
-
20.34M
87.00%
20.34M
0%
weighted average shs out dil
10.88M
-
20.34M
87.00%
20.34M
0%
eps
-0.00
-
-0.97
969,900%
-2.07
113.40%
epsdiluted
-0.00
-
-0.97
969,900%
-2.07
113.40%

All numbers in (except ratios and percentages)